Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03139877 · ClinicalTrials.gov registry record
Pediatric Obesity Observational Prospective Trial
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 295
- Enrollment target
NCT03139877 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 295 participants.
The verdict
NCT03139877 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 295 participants
- Enrollment target
Study Summary
Using an observational case-control cohort design, the investigator aims to define the mechanisms underlying microbiome regulation of metabolism in adolescence before and after medically indicated therapies for obesity. The investigator's overarching hypothesis is that gut bacteria control host weight, insulin sensitivity, and response to weight-loss treatments by modifying host metabolism.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 295 participants |
| Start Date | 2016-09-13 |
| Est. Completion | 2020-01-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03139877
The ClinicalTrials.gov registry entry for NCT03139877 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 295 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03139877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03139877 about?
NCT03139877 is a clinical study titled "Pediatric Obesity Observational Prospective Trial". Using an observational case-control cohort design, the investigator aims to define the mechanisms underlying microbiome regulation of metabolism in adolescence before and after medically indicated therapies for obesity. The investigator's overarching hypothesis is that gut bacteria control host weig...
What is the current status of trial NCT03139877?
This trial is currently completed. The enrollment target is 295 participants. The study started on 2016-09-13. Estimated completion is 2020-01-07.
Who is sponsoring clinical trial NCT03139877?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.